Alumis

ALMSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.050 B

$8.11 +2.66%

Close of 22 Sept 2026

Revenue

$24.1M

#2936 by revenue

Earnings

-$243.3M

Loss-making

Shares outstanding

126,377,692

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#154ApnimedAPMD$1.06B
#155Obsidian TherapeuticsOBX$1.05B
#156AlumisALMS$1.05B
#157Kura OncologyKURA$1.04B
#158Amphastar PharmaceuticalsAMPH$1.03B

What if Alumis were worth as much as…

Open the what-if tool →

Gold $30.2T

$233,583.76

Per share 28,802× higher

Bitcoin $1.74T

$13,455.80

Per share 1,659× higher

Nvidia $5.52T

$42,614.11

Per share 5,255× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Alumis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.